摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-pentyl 2-methylpropanoate | 54340-93-1

中文名称
——
中文别名
——
英文名称
2-pentyl 2-methylpropanoate
英文别名
sec-amyl isobutyrate;Propanoic acid, 2-methyl-, 1-methylbutyl ester;pentan-2-yl 2-methylpropanoate
2-pentyl 2-methylpropanoate化学式
CAS
54340-93-1
化学式
C9H18O2
mdl
——
分子量
158.241
InChiKey
DUNWRGFRZIHKPT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    165.2±8.0 °C(Predicted)
  • 密度:
    0.872±0.06 g/cm3(Predicted)
  • LogP:
    2.997 (est)
  • 保留指数:
    974.1;1028

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    11
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:51ac94cde18605604b09f4f91a02bf8b
查看

反应信息

  • 作为产物:
    描述:
    2-甲基丁醇异丁酸 在 Rhizomucor miehei lipase 作用下, 以 正庚烷 为溶剂, 反应 24.0h, 以97.7%的产率得到2-pentyl 2-methylpropanoate
    参考文献:
    名称:
    Divakar, Soundar, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2002, vol. 41, # 9, p. 1919 - 1922
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • PRODRUGS OF NH-ACIDIC COMPOUNDS: ESTER, CARBONATE, CARBAMATE AND PHOSPHONATE DERIVATIVES
    申请人:Blumberg Laura Cook
    公开号:US20110319422A1
    公开(公告)日:2011-12-29
    The invention provides a method of sustained delivery of a lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug by administering to a patient an effective amount of a prodrug compound of the invention wherein upon administration to the patient, release of the parent drug from the prodrug is sustained release. Prodrug compounds suitable for use in the methods of the invention are labile conjugates of parent drugs that are derivatized through carbonyl linked prodrug moieties. The prodrug compounds of the invention can be used to treat any condition for which the lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug is useful as a treatment.
    该发明提供了一种持续释放内酰胺、亚酰胺、酰胺、磺胺、碳酸酯或尿素含有母药的方法,通过向患者施用该发明的一种前药化合物的有效量,在向患者施用后,从前药中释放母药是持续释放的。适用于该发明方法的前药化合物是母药的不稳定结合物,通过羰基连接的前药基团进行衍生化。该发明的前药化合物可用于治疗任何需要内酰胺、亚酰胺、酰胺、磺胺、碳酸酯或尿素含有母药作为治疗的情况。
  • [EN] PROCESS FOR THE PREPARATION OF ACYLATED SECONDARY ALCOHOL ALKOXYLATES AND SECONDARY ALCOHOL ALKOXYLATES<br/>[FR] PROCÉDÉ DE PRÉPARATION D'ALCOXYLATES D'ALCOOLS SECONDAIRES ACYLÉS ET ALCOXYLATES D'ALCOOLS SECONDAIRES
    申请人:SHELL INT RESEARCH
    公开号:WO2010049465A1
    公开(公告)日:2010-05-06
    A process for the preparation of acylated secondary alcohol alkoxylates, said process comprising : (i) reaction of one or more internal olefins with one or more carboxylic acids in the presence of a catalyst composition in order to form one or more carboxylic acid esters; (ii) reaction of one or more carboxylic acid esters from step (i) with one or more alkylene oxide reactants, in the presence of a catalytically effective amount of a catalyst composition comprising: (a) one or more alkaline earth metal salts of carboxylic and/or hydroxycarboxylic acids and/or hydrates of the former; (b) an oxy-acid selected from sulphuric acid and ortho-phosphoric acid; (c) an alcohol and/or an ester; and/or products of the reciprocal reactions of (a), (b) and/or (c) in order to form one or more acylated secondary alcohol alkoxylates; and optionally (iii) hydrolysis or transesterification of one or more acylated secondary alcohol alkoxylates from step (ii) in order to form one or more secondary alcohol alkoxylates; and a process for making secondary alcohol alkoxy sulphates comprising the steps of: preparing secondary alcohol alkoxylates by the afore-mentioned process; and sulphating the secondary alcohol alkoxylates.
    一种制备酰化二次醇烷氧基化物的方法,该方法包括:(i)在催化剂组成物的存在下,将一种或多种内部烯烃与一种或多种羧酸反应,以形成一种或多种羧酸酯;(ii)在催化剂组成物的存在下,将步骤(i)中的一种或多种羧酸酯与一种或多种烷基氧化物反应,其中催化剂组成物包括:(a)一种或多种碱土金属羧酸和/或羟基羧酸盐和/或其水合物;(b)从硫酸和正磷酸中选择的氧酸;(c)一种醇和/或一种酯和/或(a),(b)和/或(c)的互反作用产物,以形成一种或多种酰化二次醇烷氧基化物;可选地(iii)水解或酯交换步骤,以形成一种或多种二次醇烷氧基化物。制备二次醇烷氧基硫酸盐的方法包括以下步骤:通过上述方法制备二次醇烷氧基化物;并对二次醇烷氧基化物进行硫酸化。
  • Prodrugs of NH-Acidic Compounds: Ester, Carbonate, Carbamate and Phosphonate Derivatives
    申请人:Alkermes Pharma Ireland Limited
    公开号:US20150320875A1
    公开(公告)日:2015-11-12
    The invention provides a method of sustained delivery of a lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug by administering to a patient an effective amount of a prodrug compound of the invention wherein upon administration to the patient, release of the parent drug from the prodrug is sustained release. Prodrug compounds suitable for use in the methods of the invention are labile conjugates of parent drugs that are derivatized through carbonyl linked prodrug moieties. The prodrug compounds of the invention can be used to treat any condition for which the lactam, imide, amide, sulfonamide, carbamate or urea containing parent drug is useful as a treatment.
    本发明提供了一种持续释放内酰胺、亚胺、酰胺、磺酰胺、氨基甲酸酯或尿素含量的母药的方法,通过向患者施用本发明的前药化合物的有效量,在患者体内释放母药的速率是持续释放的。适用于本发明方法的前药化合物是通过羰基偶联的前药基团衍生的母药的不稳定结合物。本发明的前药化合物可用于治疗任何需要内酰胺、亚胺、酰胺、磺酰胺、氨基甲酸酯或尿素含量的母药治疗的疾病。
  • Erasable image forming material
    申请人:KABUSHIKI KAISHA TOSHIBA
    公开号:EP0980028A1
    公开(公告)日:2000-02-16
    An erasable image forming material includes a color former, a developer, a binder resin, and a polymer decolorizer having an electron donating group capable of physically or chemically adsorbing the developer. This polymer decolorizer is, e.g., a polymer compound having a sugar skeleton, representatively starch. This image forming material can form sharp images and erase images by heat or a solvent to achieve a good erased state.
    一种可擦除图像形成材料包括显色剂、粘合剂树脂和聚合物脱色剂,聚合物脱色剂具有电子捐赠基团,能以物理或化学方式吸附显色剂。聚合物脱色剂可以是具有糖骨架的聚合物化合物,例如淀粉。这种图像形成材料可以形成清晰的图像,并通过加热或溶剂擦除图像,以达到良好的擦除状态。
  • Decolorable image forming material and decoloring method of the same
    申请人:Kabushiki Kaisha Toshiba
    公开号:EP1041447A1
    公开(公告)日:2000-10-04
    A decolorable image forming material containing a color former, a developer and a binder resin, in which the binder resin has a property that it is compatible with the color former when the material is in contact with a solvent and that it keeps the compatible state when the solvent is removed, or has a property that it shifts an equilibrium between the color former and the developer to a non-developed side when the temperature of the material is raised and that it keeps the state shifted to the non-developed side when the temperature of the material is lowered.
    一种含有显色剂、显影剂和粘合剂树脂的可脱色图像形成材料,其中粘合剂树脂具有以下特性:当材料与溶剂接触时,粘合剂树脂与显色剂相容;当溶剂移除时,粘合剂树脂保持相容状态;或者具有以下特性:当材料温度升高时,粘合剂树脂将显色剂与显影剂之间的平衡状态转移到非显影侧;当材料温度降低时,粘合剂树脂保持转移到非显影侧的状态。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物